Clinical Trial Update: Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of everolimus in metastatic colorectal cancer after failure of prior targeted therapy and chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-16